SearchDictionaryMobileLogin

Wolfgang Koenig Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

06/2008Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study.
02/2008Uric Acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis?
04/2007Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data.
04/2007Serum amyloid P component and cardiovascular disease: is there a sensible link?
01/2007Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?
10/2006Biomarkers of outcome from cardiovascular disease.
09/2006Apolipoprotein A-I and risk for cardiovascular diseases.
05/2003Update on C-reactive protein as a risk marker in cardiovascular disease.
04/2003Fibrin(ogen) in cardiovascular disease: an update.

Articles by Research Topic

Disease

16Coronary Disease (Coronary Heart Disease)
04/2007 - 07/2002
9Coronary Artery Disease (Coronary Atherosclerosis)
10/2008 - 07/2002
9Cardiovascular Diseases (Cardiovascular Disease)
06/2008 - 04/2003
8Inflammation
06/2008 - 01/2003
5Myocardial Infarction
09/2008 - 02/2005
2Type 2 Diabetes Mellitus (MODY)
10/2006 - 06/2004
2Atherosclerosis (Atheroma)
02/2005 - 04/2002
1Overweight
02/2008
1Kidney Diseases (Kidney Disease)
02/2007
1Rupture
01/2007
1Obesity
02/2006
1Acute-Phase Reaction
04/2004
1Diabetes Mellitus
01/2003
1Infection
07/2002
1Arteriosclerosis
04/2002

Drug/Important Bio-Agent (IBA)

9C-Reactive ProteinIBA
05/2008 - 07/2002
51-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2008 - 09/2005
3Biological Markers (Surrogate Marker)IBA
02/2008 - 10/2006
3rosiglitazone (Avandia)FDA Link
04/2006 - 02/2003
2Fibrinogen (Factor I)IBA
09/2008 - 07/2007
2Uric Acid (Urate)IBA
06/2008 - 02/2008
2AdiponectinIBA
10/2006 - 08/2005
2ChemokinesIBA
09/2006 - 01/2006
1pioglitazone (Actos)FDA Link
10/2008
1DNA (Deoxyribonucleic Acid)IBA
05/2008
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)FDA Link
01/2008
1Interleukin-6 (Interleukin 6)IBA
07/2007
1Serum Amyloid P-ComponentIBA
04/2007
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
04/2007
1polypeptide CIBA
12/2006
1CreatinineIBA
12/2006
1Apolipoprotein A-I (Apolipoprotein A1)IBA
09/2006
1CollagenIBA
04/2006
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2006
1Lipoproteins (Lipoprotein)IBA
09/2005
1oxidized low density lipoproteinIBA
08/2005
1ApolipoproteinsIBA
02/2005
1Interleukin-1 (Interleukin 1)IBA
01/2005
1GlucokinaseIBA
06/2004
1PPAR alphaIBA
04/2004
1Procetofen (CiL)FDA LinkGeneric
04/2004
1Lipoprotein(a)IBA
10/2003
1Estradiol (Estrace)FDA LinkGeneric
05/2003
1CD40 Ligand (CD40L)IBA
04/2003
1estropipate (Ogen)FDA LinkGeneric
04/2003
1FibrinIBA
04/2003
1PPAR gammaIBA
02/2003
1PlasminogenIBA
11/2002
1Acute-Phase Proteins (Acute-Phase Protein)IBA
11/2002
1endotoxin receptorIBA
07/2002
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2002

Therapy/Procedure

1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2003
1Transplantation (Transplant Recipients)
04/2002